IL2 and hepatocellular carcinoma: Treatment with PD‐L1 siRNA and IL‐2 pDNA‐loaded TT‐LDCP NPs significantly suppressed the tumor growth and metastasis compared to that treated with TT‐LDCP loaded with control siRNA and HCC vaccine.